Skip to main content

Pain in Respiratory Disease

  • Chapter
  • First Online:
Integrated Palliative Care of Respiratory Disease

Abstract

Pain may be classified as nociceptive or neuropathic and somatic or visceral. Neuropathic pain can be further subdivided into that due to nerve compression, nerve destruction or sympathetically maintained pain. The chapter describes the assessment and diagnosis of the cause of pain and the concepts of total pain and regular and breakthrough pain. Management starts with explanation and general non-drug measures. Disease modification runs alongside the use of non-opioid analgesics and then the WHO opioid ladder. Oral morphine is the main strong opioid used, but the indication for alternative drugs and routes is considered. Neuropathic pain ­usually requires the use of adjuvant analgesics. The role of other adjuvants in certain circumstances is described as well as the use of topical analgesics and anesthetic interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Blinderman CD, Homel P, Billings P, et al. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage. 2009;38(1):115–23.

    Article  PubMed  Google Scholar 

  2. Lohne V, Heer HC, Anderson M, et al. Qualitative study of pain of patients with chronic obstructive pulmonary disease. Heart Lung. 2010;39(3):226–34.

    Article  PubMed  Google Scholar 

  3. Borge CR, Wahl AK, Moum T. Association of breathlessness with multiple symptoms in chronic obstructive pulmonary disease. J Adv Nurs. 2010;66(12):2688–700.

    Article  PubMed  Google Scholar 

  4. Portenoy RK, Miransky J, Thaler HT, et al. Pain in ambulatory patients with lung or colon cancer. Cancer. 1992;70(6):1616–24.

    Article  PubMed  CAS  Google Scholar 

  5. Claessens MT, Lynn J, Zhong Z, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J Am Geriatr Soc. 2000;48(5):146–53.

    Google Scholar 

  6. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985–91.

    Article  PubMed  CAS  Google Scholar 

  7. Foley KM. How well is cancer pain treated? Palliat Med. 2011;25(5):398–401.

    Article  PubMed  Google Scholar 

  8. Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64:107–14.

    Article  PubMed  CAS  Google Scholar 

  9. Stute P, Soukup J, Menzel M, Sabatowski R, Grond S. Analysis and treatment of different types of neuropathic cancer pain. J Pain Symptom Manage. 2003;26(6):1123–31.

    Article  PubMed  Google Scholar 

  10. von der Lippe B, Sandven P, Brubakk O. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB) – a report of ten cases. J Infect. 2006;52(2):92–6.

    Article  PubMed  Google Scholar 

  11. Lema MJ, Foley KM, Hausheer FH. Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain. Oncologist. 2010;15 Suppl 2:3–8.

    Article  PubMed  Google Scholar 

  12. Blumenthal DT, Blumenthal DT. Assessment of neuropathic pain in cancer patients. Curr Pain Headache Rep. 2009;13(4):282–7.

    Article  PubMed  Google Scholar 

  13. Desbiens NA, Wu AW, Broste SK, Wenger NS, Connors Jr AF, Lynn J, Yasui Y, Phillips RS, Fulkerson W. Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. Crit Care Med. 1996;24(12):1953–61.

    Article  PubMed  CAS  Google Scholar 

  14. Brevik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment and patient attitudes. Ann Oncol. 2009;20:1420–33.

    Article  Google Scholar 

  15. Clayton HA, Reschak GLC, Gaynor SE, Creamer JL. A novel program to assess and manage pain. Medsurg Nurs. 2000;9(6):318–22.

    PubMed  CAS  Google Scholar 

  16. WHO pain ladder.www.who.int/cancer/palliative/painladder/en/index.html. Accessed 30 Nov 2011.

  17. McQuay H. Evidence-based medicine: what is the evidence that it has made a difference? Palliat Med. 2011;25(5):394–7.

    Article  PubMed  Google Scholar 

  18. Wilkinson S, Barnes K, Storey L. Massage for symptom relief in patients with cancer: systematic review. J Adv Nurs. 2008;63(5):430–9.

    Article  PubMed  Google Scholar 

  19. Paley CA, Johnson MI, Tashani OA, Bagnall AM. Acupuncture for cancer pain in adults. Cochrane Database Syst Rev. 2011;(1):CD007753. doi:10.1002/14651858.CD007753.pub2.

  20. Robb KA, Bennett MI, Johnson MI, Simpson KJ, Oxberry SG. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. Cochrane Database Syst Rev. 2008;(3):CD006276. doi:10.1002/14651858.CD006276.pub2.

  21. Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol. 1972;240(102):200–3.

    PubMed  CAS  Google Scholar 

  22. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12(1):46–55.

    Article  PubMed  Google Scholar 

  23. Axelsson B, Christensen S. Is there an additive analgesic effect of paracetamol at step 3? A double-blind randomised controlled study. Palliat Med. 2003;17:724–5.

    Article  PubMed  Google Scholar 

  24. Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol. 2004;22(16):3389–94.

    Article  PubMed  CAS  Google Scholar 

  25. Buria M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther. 2005;107:139–54.

    Article  Google Scholar 

  26. Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002;53:25–57.

    Article  Google Scholar 

  27. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520–8.

    Article  PubMed  CAS  Google Scholar 

  28. Finckh A, Aronson MD. Cardiovascular risks of cyclooxygenase-2 inhibitors: where do we stand now? Ann Intern Med. 2005;142:212–4.

    PubMed  Google Scholar 

  29. Topol EJ. Arthritis medicines and cardiovascular events – “house of coxibs”. J Am Med Assoc. 2005;293:366–8.

    Article  CAS  Google Scholar 

  30. Rostom A, Dube C, Wells GA, Tugwell P, Welch V, Jolicoeur E, McGowan J, Lanas A. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev. 2002;(4):CD002296. doi:10.1002/14651858.CD002296.

  31. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspiring induced asthma and its implications for clinical practice. Br Med J. 2004;328:434.

    Article  CAS  Google Scholar 

  32. Venturini C, Isakson P, Needleman P. Nonsteroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclooxygenase isoforms. Curr Opin Nephrol Hypertens. 1998;7(1):79–82.

    Article  PubMed  CAS  Google Scholar 

  33. Schneider V, Lévesque L, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional nonsteroidal anti-inflammatory drugs with acute renal failure: a population based, nested case–control analysis. Am J Epidemiol. 2006;164(9):881–9.

    Article  PubMed  Google Scholar 

  34. Twycross R, Wilcock A, editors. PCF4 – Palliative care formulary. 4th ed. Nottingham: ­palliativedrugs.com; 2011. p. 355.

    Google Scholar 

  35. Lewis KS, Han NH. Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm. 1997;54(6):643–52.

    PubMed  CAS  Google Scholar 

  36. Borgbjerg FM, Nielsen K, Franks J. Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain. 1996;64:123–8.

    Article  PubMed  CAS  Google Scholar 

  37. Wiffen PJ, McQuay HJ, Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2007;(4):CD003868. doi:10.1002/14651858.CD003868.pub2.

  38. Mercadante S. Opioid titration in cancer pain: a critical review. Eur J Pain. 2007;11(8):823–30.

    Article  PubMed  CAS  Google Scholar 

  39. Radbruch L, Sabatowski R, Loick G, Kulbe C, Kasper M, Grond S, Lehmann KA. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med. 2000;14(2):111–9.

    Article  PubMed  CAS  Google Scholar 

  40. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004;28(5):497–504.

    Article  PubMed  CAS  Google Scholar 

  41. Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA. Assessment and ­treatment of neuropathic cancer pain following WHO guidelines. Pain. 1999;79(1):15–20.

    Article  PubMed  CAS  Google Scholar 

  42. Twycross R, Wilcock A, editors. PCF4 – Palliative care formulary. 4th ed. Nottingham: ­palliativedrugs.com; 2011. p. 283.

    Google Scholar 

  43. Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain. 1999;80:453–62.

    Article  PubMed  CAS  Google Scholar 

  44. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454. doi:10.1002/14651858.CD005454.pub2.

  45. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;(3):CD007938. doi:10.1002/14651858.CD007938.pub2.

  46. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;(3):CD007076. doi:10.1002/14651858.CD007076.pub2.

  47. Mannix K, Ahmedzai SH, Anderson H, Bennett M, Lloyd-Williams M, Wilcock A. Using bisphosphonates to control the pain of bone metastases: evidence based guidelines for ­palliative care. Palliat Med. 2000;14:455–61.

    Article  PubMed  CAS  Google Scholar 

  48. Tytgat GN. Hyoscine butylbromide – a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin. 2008;24(11):3159–73.

    Article  PubMed  CAS  Google Scholar 

  49. Khaliq W, Alam S, Puri NK. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2007;(2):CD004846. doi:10.1002/14651858.CD004846.pub2.

  50. Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2009;(4):CD007393. doi:10.1002/14651858.CD007393.pub2.

  51. Massey T, Derry S, Moore RA, McQuay HJ. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev. 2010;(6):CD007402. doi:10.1002/14651858.CD007402.pub2.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eleanor Grogan B.Sc., M.B.B.S., M.A., FRCP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Grogan, E. (2013). Pain in Respiratory Disease. In: Bourke, S., Peel, E. (eds) Integrated Palliative Care of Respiratory Disease. Springer, London. https://doi.org/10.1007/978-1-4471-2230-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2230-2_5

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2229-6

  • Online ISBN: 978-1-4471-2230-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics